ECPLA explained

ECPLA (N-ethyl-N-cyclopropyllysergamide) is an analog of lysergic acid diethylamide (LSD) developed by Synex Synthetics. In studies in mice, it was found to have approximately 40% the potency of LSD.^{[1] [2]}

See also

• ETFELA
• Methylisopropyllysergamide

Notes and References

1. Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD . 6 . Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) . Psychopharmacology . 236 . 2 . 799–808 . February 2019 . 30298278 . 6848745 . 10.1007/s00213-018-5055-9 .
2. Wagmann L, Richter LH, Kehl T, Wack F, Bergstrand MP, Brandt SD, Stratford A, Maurer HH, Meyer MR . 6 . In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures . Analytical and Bioanalytical Chemistry . 411 . 19 . 4751–4763 . July 2019 . 30617391 . 10.1007/s00216-018-1558-9 . 58615418 .